SCHEMBL6465780

SCHEMBL6465780

CCCNCCCCc1ccc(OC)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.62
CALM1 P0DP23 1/20 0.51
IGF1R P08069 1/20 0.50
ALOX15 P16050 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
HTT P42858 1/20 0.49
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
ALOX12 P18054 1/20 0.48
MAPK1 P28482 1/20 0.48
KMT2A Q03164 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
S1PR2 O95136 1/20 0.48
S1PR1 P21453 1/20 0.48
S1PR3 Q99500 1/20 0.48
SIGMAR1 Q99720 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275640 0.95 CHRM2 (0.59) CHRM2CALM1SMN1; SMN2HTTMEN1
SCHEMBL6469311 0.87 SMN1; SMN2 (0.57) CHRM2SMN1; SMN2HTTMEN1ALDH1A1
Hydrochloric Acid SCHEMBL9740760 0.86 SMN1; SMN2 (0.56) CHRM2SMN1; SMN2HTTMEN1ALDH1A1
SCHEMBL11808217 0.83 CHRM2 (0.63) CHRM2CALM1IGF1RALOX15SMN1; SMN2
SCHEMBL6835324 0.82 CHRM2 (0.56) CHRM2CALM1SMN1; SMN2HTTSIGMAR1
SCHEMBL9372179 0.82 SIGMAR1 (0.72) CHRM2MEN1KMT2AL3MBTL1SIGMAR1
SCHEMBL10568997 0.81 CASP3 (0.63) CHRM2CALM1IGF1RALOX15SMN1; SMN2
SCHEMBL581719 0.81 CASP3 (0.63) CHRM2CALM1IGF1RALOX15SMN1; SMN2
SCHEMBL10570923 0.81 CALM1 (0.62) CALM1IGF1RALOX15SMN1; SMN2MEN1
SCHEMBL10569250 0.81 CALM1 (0.62) CALM1IGF1RALOX15SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531811-A2 DERIVATIVES OF 3-HYDROXY-4-(CYCLYL-ALKYLAMINOALKYL)-5-PHENYL-1H-PYRAZOLE AS ANTAGONISTS OF THE GONADOTROPIN RELEASING HORMONE (GNRH) FOR USE IN THE TREATMENT OF SEX HORMONE RELATED CONDITIONS, SUCH AS PROSTATIC OF UTERINE CANCER AstraZeneca AB (SE) 2005-05-25 EP claimed
WO-2004017961-A2 DERIVATIVES OF 3-HYDROXY-4-(CYCLYL-ALKYLAMINOALKYL)-5-PHENYL-1H-PYRAZOLE AS ANTAGONISTS OF THE GONADOTROPIN RELEASING HORMONE (GNRH) FOR USE IN THE TREATMENT OF SEX HORMONE RELATED CONDITIONS, SUCH AS PROSTATIC OF UTERINE CANCER ASTRAZENECA AB (SE) 2004-03-04 WO claimed